Favorable outcome of liver transplantation despite a high hepatitis B virus replication: Beyond the limits?

Transplant Infectious Disease

Volumn 8, Issue 3, 2006, Pages 182-184

  Dumortier, J ^a   Le Derf, Y ^a   Guillem, P ^a   Chevallier, P ^b   Boillot, O ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b Lab d'Hygiene et d'Immunologie   (France)

Author keywords

Adefovir; Hepatitis B; Hepatitis B immune globulin; Lamivudine; Liver transplantation

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; BILIRUBIN; GANCICLOVIR; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHRONIC HEPATITIS; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; JAUNDICE; LIVER BIOPSY; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION;

ADENINE; ANTIVIRAL AGENTS; HEPATITIS B; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PHOSPHONIC ACIDS; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 33746910565     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2006.00135.x     Document Type: Article

References (11)

1. SAMUEL D, BISMUTH A, MATHIEU D, et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 1991: 337: 813-815.
2. SAWYER RG, MCGORY RW, GAFFEY MJ, et al. Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization. Ann Surg 1998: 227: 841-850.
3. STEINMULLER T, SEEHOFER D, RAYES N, et al. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease. Hepatology 2002: 35: 1528-1555.
4. KIM WR, POTERUCHA JJ, KREMERS WK, et al. Outcome of liver transplantation for hepatitis B in the United States. Liver Transpl 2004: 10: 968-974.
5. VILLENEUVE JP, CONDREAY LD, WILLEMS B, et al. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology 2000: 31: 207-210.
6. ROCHE B, SAMUEL D. Evolving strategies to prevent HBV recurrence. Liver Transpl 2004: 10: S74-S85.
7. ANDREONE P, BISELLI M, GRAMENZI A, et al. Efficacy of lamivudine therapy for advanced liver disease in patients with precore mutant hepatitis B virus infection awaiting liver transplantation. Transplantation 2002: 74: 1119-1124.
8. LOK AS. Liver transplantation for patients with lamivudine-resistant HBV: what is the optimal prophylactic strategy? Liver Transpl 2005: 11: 490-493.
9. SCHIFF ER, LAI CL, HADZIYANNIS S, et al. Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. Hepatology 2003: 38: 1419-1427.
10. MARZANO A, LAMPERTICO P, MAZZAFERRO V, et al. Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants. Liver Transpl 2005: 11: 532-538.
11. BOZKAYA H, YURDAYDIN C, BOZDAYI AM, et al. Oral ganciclovir for treatment of lamivudine-resistant hepatitis B virus infection: a pilot study. Clin Infect Dis 2002: 35: 960-965.